HAVN Life Sciences Inc.
HAVN Life Sciences Inc. is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs and the development of natural health products and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, the company offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.
HAVN Life Sciences Inc. (HAVN)
Réservé à l'émission:2,493,298
Communiqués de presse
le 31 janvier/January 2023
Effective immediately, HAVN Life Sciences Inc. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.